{
  "LinkTitle": "D-2022-1596",
  "Status": "Initial",
  "InitialDMPReviewStatus": "Reviewed",
  "Funder": "IOF",
  "ProjectTitle": "Validation of TRPM3 as a target for neuropathic pain",
  "InitialFeedbackHistory": "16/05/2022\r\n2. Please briefly describe the methods that you are using to generate the datasets and origin of the samples/models. Please also include physical data: samples, animal models etc. You don't have to mention documentation and manuscripts here.  \n3. Ethics: Please include the ECD approval number and UZL ethics and biobank approval numbers for the use of human tissues. Under 5 you mention the 2008 law but make sure you study is compliant with the 2018 biobank law. For more information: www.uzleuven.be/en/uz-kuleuven-biobank. You also mention private data under 5 while you write that you are not using personal data under 3, please list your privacy approval number if you collect personal data. \n4,5,6 Documentation, Storage, Preservation: You give a lot of information here for some of which I don't see a direct link with the data that you are mentioning in 2. Is all of this information relevant for this specific project? It would be helpful to indicate per dataset which documentation and storage you are using. \n7. Data sharing: Have you considered any specific repositories to preserve and share your data? You can also use KU Leuven RDR (https://www.kuleuven.be/rdm/en/rdr) or domain specific repositories; F1000 research also gives a good list of recommendations (https://f1000research.com/for-authors/data-guidelines). \nPlease revise your DMP and only mention what is relevant for your specific study and upload your updated DMP as intermediate DMP. If you work with personal data, human participants or human bodily material ensure you have ethics and privacy approval before starting and list the reference numbers in your DMP.",
  "label": "good with suggestions"
}